
In this episode of the Medical Sales Podcast, Samuel Adeyinka sits down with Kweku Larbie, an immunology sales representative at Johnson & Johnson, to explore what it's really like to sell specialty pharmaceuticals in gastroenterology. Kweku explains how biologic therapies for Crohn's disease and ulcerative colitis differ from traditional pharmaceutical products, why specialty sales comes with greater complexity and higher earning potential, and what it takes to support physicians treating patients with chronic autoimmune diseases. He also shares insights into the launch of Tremfya in gastroenterology, the realities of selling within a highly specialized therapeutic area, and the profound impact these therapies can have on patients' quality of life. This episode is a must listen for anyone interested in specialty pharmaceutical sales, immunology, or advancing into high value medical sales roles. Connect with Steve Gielda: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How »
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

What It Actually Takes to Break Into Medical Device Sales

If I Had to Break Into Medical Sales Again in 2026, Here's What I'd Do

From Student to $27 Million Medical Sales Entrepreneur in 3 Years

Life Inside Cardiac Rhythm Management Sales: The Reality Nobody Shows Us
Free AI-powered recaps of The Medical Sales Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.